Medical research is experiencing transformative innovations. One such development is Proteolysis-Targeting Chimera (PROTACs), a revolutionary drug class which tags disease-inducing proteins for degradation, potentially leading to more specific and less side-effect prone medications. AI is also changing the face of scientific publishing, automating traditionally laborious processes like manuscript screening and plagiarism checks, thereby improving peer-review procedures. Other breakthroughs include new insights into the impact of imperfect adherence to HIV pre-exposure prophylaxis, the development of a new quadrivalent vaccine for cervical cancer, and the usage of CRISPR screens and tumor organoids in cancer treatment. These developments signify important strides towards improving patient care and addressing various health conditions.
Full article here: https://lawsuithelpdesk.com/unveiling-medical-breakthroughs-from-revolutionary-drug-classes-to-the-power-of-ai-in-scientific-publishing/